As of 2024-10-03, the Relative Valuation of Ligand Pharmaceuticals Inc (LGND) is 103.24 USD. This relative valuation is based on P/E multiples. With the latest stock price at 102.24 USD, the upside of Ligand Pharmaceuticals Inc based on Relative Valuation is 1.0%.
The range of the Relative Valuation is 73.61 - 135.13 USD.
| Range | Selected | |
| Trailing P/E multiples | 50.4x - 58.6x | 54.5x |
| Forward P/E multiples | 25.2x - 30.5x | 27.6x |
| Fair Price | 73.61 - 135.13 | 103.24 |
| Upside | -28.0% - 32.2% | 1.0% |
| Date | P/E |
| 2024-10-03 | 44.32 |
| 2024-10-02 | 43.33 |
| 2024-10-01 | 43.93 |
| 2024-09-30 | 43.39 |
| 2024-09-27 | 42.21 |
| 2024-09-26 | 43.08 |
| 2024-09-25 | 42.82 |
| 2024-09-24 | 43.15 |
| 2024-09-23 | 43.20 |
| 2024-09-20 | 44.56 |
| 2024-09-19 | 45.52 |
| 2024-09-18 | 44.94 |
| 2024-09-17 | 45.20 |
| 2024-09-16 | 45.52 |
| 2024-09-13 | 45.42 |
| 2024-09-12 | 44.26 |
| 2024-09-11 | 44.69 |
| 2024-09-10 | 44.32 |
| 2024-09-09 | 44.55 |
| 2024-09-06 | 43.84 |
| 2024-09-05 | 44.71 |
| 2024-09-04 | 44.46 |
| 2024-09-03 | 43.76 |
| 2024-08-30 | 45.86 |
| 2024-08-29 | 45.89 |
| 2024-08-28 | 46.18 |
| 2024-08-27 | 46.09 |
| 2024-08-26 | 45.60 |
| 2024-08-23 | 45.01 |
| 2024-08-22 | 44.92 |
| 2024-08-21 | 45.98 |
| 2024-08-20 | 45.23 |
| 2024-08-19 | 44.91 |
| 2024-08-16 | 44.31 |
| 2024-08-15 | 44.71 |
| 2024-08-14 | 43.79 |
| 2024-08-13 | 44.66 |
| 2024-08-12 | 43.18 |
| 2024-08-09 | 43.42 |
| 2024-08-08 | 42.01 |
| 2024-08-07 | 40.45 |
| 2024-08-06 | 42.93 |
| 2024-08-05 | 42.54 |
| 2024-08-02 | 43.43 |
| 2024-08-01 | 45.21 |
| 2024-07-31 | 47.25 |
| 2024-07-30 | 47.73 |
| 2024-07-29 | 47.14 |
| 2024-07-26 | 46.44 |
| 2024-07-25 | 45.95 |